High Yield Overview

SPECT-CT Applications

Combining Functional and Anatomical Imaging for Orthopaedic Diagnosis

SPECTSingle Photon Emission Computed Tomography

CTCo-registered anatomical imaging

3DVolumetric functional data vs 2D planar scan

30%Additional diagnoses changed by SPECT-CT over planar

PatellaKey application: patellofemoral assessment

FusionAssessment of spinal fusion solidity

TKRPainful prosthesis evaluation

FacetJoint localisation for diagnostic block

SPECT-CT vs Planar Bone Scan vs PET-CT

Planar bone scan: 2D, whole-body, sensitive but poor anatomical localisation, lowest dose

SPECT-CT: 3D, regional, better contrast resolution, precise anatomical localisation, moderate dose

PET-CT: 3D, whole-body or regional, superior resolution and specificity, highest dose

Key: SPECT-CT bridges the gap between the low-cost whole-body planar bone scan and the expensive high-resolution PET-CT

Critical Must-Knows

SPECT acquires 3D nuclear medicine data (like CT does for X-rays), providing volumetric functional information compared to the 2D planar bone scan.
SPECT-CT combines SPECT functional data with CT anatomical data through co-registration — localising the metabolic abnormality to a specific anatomical structure.
SPECT-CT adds diagnostic value in approximately 30% of cases over planar bone scan, often changing the clinical management.
Key orthopaedic applications: painful arthroplasty evaluation, patellofemoral assessment, spinal fusion assessment, facet joint disease localisation, and stress fracture detection.
SPECT-CT is particularly valuable when the planar bone scan shows uptake in a complex anatomical region (spine, wrist, foot) where precise localisation is needed.

Examiner's Pearls

"
SPECT provides better contrast resolution and sensitivity than planar bone scan — it detects lesions that are invisible on the planar study.
"
The CT component serves dual purposes: attenuation correction (improving SPECT accuracy) and anatomical localisation of uptake.
"
In painful total knee replacement, SPECT-CT can differentiate patellofemoral from tibiofemoral sources of uptake — guiding targeted revision.
"
For spinal fusion assessment, SPECT-CT can confirm whether a fusion is solid (no uptake) or actively remodelling/pseudarthrosis (focal uptake at the fusion site).
"
SPECT-CT dose is higher than planar bone scan alone due to the CT component (typically 3-10 mSv additional).

Exam Warning

SPECT-CT is examined in the context of specific clinical indications where its hybrid nature adds diagnostic value. You must understand: how SPECT differs from planar bone scan (3D vs 2D), why the CT component is essential (anatomical localisation and attenuation correction), and the specific orthopaedic applications — particularly painful arthroplasty, spinal fusion assessment, and stress fracture localisation. A common viva question involves explaining when SPECT-CT changes management compared to planar bone scan alone.

Mnemonic

FOCUSSPECT-CT Advantages

Functional data in 3D

SPECT provides volumetric 3D functional data, detecting lesions with 20-30% better contrast than planar scanning

Overlay with CT anatomy

Co-registration of SPECT and CT precisely localises the metabolic abnormality to a specific anatomical structure

Characterise the abnormality

CT component shows the structural correlate (arthritis, fracture, hardware loosening) of the functional uptake

Upgraded diagnosis (30% of cases)

SPECT-CT changes the diagnosis or management in approximately 30% of cases compared to planar bone scan alone

Specific localisation in complex regions

Critical for the spine, wrist, foot, and around prostheses — where planar bone scan cannot distinguish adjacent structures

Memory Hook:FOCUS: SPECT-CT focuses the functional information onto the precise anatomical source — essential when planar scan is non-specific.

Mnemonic

PSFATKey Orthopaedic SPECT-CT Indications

Painful prosthesis evaluation

Localises uptake to specific prosthetic interfaces (tibial, femoral, patellar) — guides targeted revision surgery

Spinal fusion assessment

Determines whether a fusion segment has achieved solid union (no uptake) or has pseudarthrosis (active uptake)

Facet joint disease localisation

Identifies the specific facet joint(s) responsible for back pain — guides diagnostic blocks and radiofrequency ablation

Arthritis characterisation

Differentiates patellofemoral from tibiofemoral compartment disease. Identifies the pain-generating compartment

Tarsal and carpal pathology

Localises uptake to specific small bones in the foot (navicular stress fracture) or wrist (scaphoid nonunion)

Memory Hook:PSFAT: the five key applications where SPECT-CT adds value beyond planar bone scan.

Mnemonic

RALSPECT-CT Technology

Rotating gamma camera

SPECT uses a rotating gamma camera that acquires data from multiple angles (120-360 degrees) to reconstruct a 3D volume

Attenuation correction by CT

The CT scan corrects for tissue attenuation differences, improving SPECT quantitative accuracy — particularly important around metal implants

Localisation by co-registration

SPECT and CT images are acquired sequentially on the same gantry, ensuring precise co-registration without requiring patient repositioning

Memory Hook:RAL: Rotating camera for 3D, Attenuation correction for accuracy, Localisation to anatomy.

Overview

SPECT-CT (Single Photon Emission Computed Tomography combined with Computed Tomography) is a hybrid imaging modality that combines the functional sensitivity of nuclear medicine with the anatomical precision of CT. This combination has become increasingly valuable in orthopaedic practice, particularly for solving diagnostic problems where planar bone scan provides insufficient anatomical localisation.

The fundamental principle is straightforward: planar bone scan tells you there is increased bone turnover somewhere in a region, but in anatomically complex areas (spine, wrist, tarsus, around prostheses), it cannot localise the uptake to a specific structure. SPECT-CT resolves this limitation by: (1) acquiring 3D nuclear medicine data (SPECT) with better contrast resolution than 2D planar imaging, and (2) co-registering this functional data with a CT scan that provides the anatomical framework.

When SPECT-CT Adds Value

SPECT-CT is most valuable when: (1) Planar bone scan shows uptake in a complex anatomical region where the source structure cannot be identified. (2) Evaluation of painful arthroplasty where precise compartmental localisation guides surgical planning. (3) Spinal fusion assessment where the question is whether a fusion is solid. (4) Back pain workup to identify the specific facet joint responsible. (5) Stress fracture localisation in complex anatomy (tarsal navicular, carpal bones). Studies show SPECT-CT changes the diagnosis in approximately 30% of cases and changes management in approximately 25%.

Limitations of SPECT-CT

SPECT-CT has lower spatial resolution than dedicated diagnostic CT or MRI (SPECT resolution approximately 7-10mm). The CT component is typically low-dose and is NOT equivalent to a diagnostic CT scan — it is primarily for localisation and attenuation correction. The additional radiation from the CT component (typically 3-10 mSv) must be justified by the clinical need. SPECT-CT is regional (not whole-body like planar scan), requiring the operator to select the region of interest. Availability is more limited than standard planar bone scan.

Clinical Imaging

Imaging Gallery

SPECT-CT demonstrating co-registered functional and anatomical imaging in orthopaedic application — SPECT-CT demonstrating the co-registration of functional (SPECT) and anatomical (CT) data. The SPECT component shows areas of increased metabolic activity, while the CT component provides precise anatomical localisation. The fused image identifies the specific structure responsible for the uptake — information that is often impossible to determine from planar bone scan alone.Credit: Open-i (NIH) (Open Access (CC BY))

SPECT-CT showing precise anatomical localisation of uptake for clinical decision-making — SPECT-CT fusion image showing the precise localisation of uptake to a specific anatomical structure. This level of anatomical precision is crucial for guiding clinical decision-making, particularly in complex regions where planar bone scan cannot differentiate adjacent structures.Credit: Open-i (NIH) (Open Access (CC BY))

Systematic Approach

Systematic SPECT-CT Interpretation

SPECT-CT Interpretation Framework

Step	Assessment	Key Principles
1. Correlation with planar study	Compare SPECT-CT findings with the whole-body planar bone scan	SPECT-CT is regional — the planar study ensures no significant distant findings are missed
2. SPECT data assessment	Assess 3D uptake patterns: location, intensity, distribution	SPECT provides better contrast than planar — it may reveal additional lesions not seen on the 2D study
3. CT anatomical review	Review the CT component for structural correlates	Look for arthritis, fracture lines, hardware position, lytic/blastic lesions, soft tissue changes
4. Fusion image analysis	Analyse the co-registered SPECT/CT fusion images	Determine which specific anatomical structure the SPECT uptake localises to — this is the key diagnostic step
5. Clinical correlation	Integrate findings with clinical history, examination, and other imaging	Consider whether the SPECT-CT findings explain the patient's symptoms and guide management
6. Management impact	Assess whether SPECT-CT changes or confirms the diagnosis and management plan	Document how SPECT-CT adds value — this justifies the additional radiation dose

Clinical Applications

SPECT-CT for Painful Prosthesis

One of the most valuable orthopaedic applications of SPECT-CT is the assessment of painful total joint replacements, particularly total knee replacements (TKR).

The clinical problem: After TKR, approximately 15-20% of patients experience persistent pain. The source of pain may be patellofemoral maltracking, component malalignment, tibial or femoral component loosening, or soft tissue impingement. Planar bone scan often shows generalised periarticular uptake that cannot differentiate these sources.

SPECT-CT contribution: By co-registering the 3D uptake data with CT anatomy, SPECT-CT can localise uptake to: (1) the patellofemoral compartment (suggesting patellar maltracking or patella button loosening), (2) the tibial tray (suggesting tibial loosening or tibial component malalignment), (3) the femoral component (suggesting femoral loosening), or (4) specific soft tissue structures. This compartmental localisation directly guides targeted revision — for example, if SPECT-CT shows isolated patellofemoral uptake, an isolated patellar revision or lateral release may be appropriate rather than a full revision.

CT component assessment: In TKR evaluation, the CT also provides: (1) component alignment assessment (rotation, valgus/varus), (2) evidence of osteolysis, (3) cement mantle integrity, (4) implant position relative to the mechanical axis. Combined with the metabolic SPECT data, this gives a comprehensive functional-anatomical assessment.

Normal periprosthetic uptake can persist for 1-2 years post-surgery — SPECT-CT at less than 2 years must be interpreted with caution.

Evidence Base

SPECT-CT for Painful Total Knee Replacement

Prospective Study

Hirschmann MT, Iranpour F, Konala P, Kerner A, Rasch H, Cobb JP, Friederich NF • Clinical Orthopaedics and Related Research (2010)

Key Findings:

SPECT-CT changed the diagnosis in 32% of patients with painful TKR compared to planar bone scan alone.
SPECT-CT localised uptake to specific prosthetic compartments (patellofemoral vs tibiofemoral) with high accuracy.
Component malalignment detected on CT correlated with focal SPECT uptake at the affected interface.

Clinical Implication: SPECT-CT should be considered a standard investigation for the painful TKR workup — it changes management in approximately one-third of cases.

Limitation: Normal postoperative uptake persists for 1-2 years, limiting the utility of SPECT-CT in the early postoperative period.

Source: Hirschmann MT et al. Clin Orthop Relat Res 2010;468(3):769-76

SPECT-CT Value Added Over Planar Bone Scan

Systematic Review

Huellner MW, Strobel K • Clinical and Translational Imaging (2014)

Key Findings:

SPECT-CT changed the diagnosis in 25-35% of orthopaedic cases across indications.
The greatest value was seen in the spine (facet localisation), around prostheses, and in the foot and ankle.
SPECT-CT changed clinical management in 20-30% of cases, primarily by enabling more targeted interventions.

Clinical Implication: SPECT-CT is a proven upgrade over planar bone scan for orthopaedic applications — its use should be guided by the clinical question.

Limitation: The additional radiation dose from CT must be justified. Not all cases benefit — SPECT-CT adds most value in complex anatomical regions.

Source: Huellner MW, Strobel K. Clin Transl Imaging 2014;2(4):283-96

SPECT-CT consistently changes diagnosis and management for painful arthroplasty.

Australian Context

In Australia, SPECT-CT is available in most major nuclear medicine departments in both public and private settings. The study is increasingly requested by orthopaedic surgeons and spinal surgeons for specific indications where its hybrid functional-anatomical capabilities add diagnostic value beyond standard planar bone scan.

SPECT-CT is funded under the standard nuclear medicine bone scan category, with the CT component included in the examination protocol at the discretion of the nuclear medicine specialist. There is no separate additional funding for the CT component in most Australian settings, which means the decision to perform SPECT-CT is a clinical one based on the anticipated diagnostic benefit.

Australian nuclear medicine practice follows RANZCR and AANMS guidelines for SPECT-CT protocols, including radiation dose optimisation for the CT component (using the lowest dose protocol that achieves adequate anatomical localisation and attenuation correction). The availability of SPECT-CT has expanded the role of nuclear medicine in the orthopaedic workup algorithm in Australian practice.

Exam Viva Scenarios

Practice these scenarios to excel in your viva examination

VIVA SCENARIOStandard

EXAMINER

"A 55-year-old patient presents with anterior knee pain 3 years after total knee replacement. A planar bone scan shows diffuse periarticular uptake around the TKR. You are asked about the role of SPECT-CT."

EXCEPTIONAL ANSWER

This is a common and important clinical scenario where SPECT-CT adds significant diagnostic value. The planar bone scan shows diffuse periarticular uptake around the TKR at 3 years — by this stage, normal postoperative uptake should have resolved (usually settles by 1-2 years). The problem with the planar scan is that diffuse uptake does not tell us whether the source is the patellofemoral compartment, the medial or lateral tibiofemoral compartment, or a combination. This distinction is critical because it determines the surgical approach. SPECT-CT would provide: (1) SPECT component: 3D functional data with better contrast than planar imaging, potentially revealing the specific pattern of uptake (focal vs diffuse, patellofemoral vs tibiofemoral). (2) CT component: assessment of component alignment (rotation, flexion angle, tibial slope), evidence of osteolysis, cement mantle integrity, patellar tracking, and periprosthetic bone quality. (3) Fusion images: precise localisation of metabolic activity to specific prosthetic interfaces — for example, if uptake localises predominantly to the patellar button interface, this suggests patellar maltracking or loosening. If uptake is at the tibial baseplate, this suggests tibial component loosening. Clinical impact: In published studies, SPECT-CT changes the diagnosis in approximately 30% of painful TKR cases compared to planar bone scan alone. In an anterior knee pain scenario, SPECT-CT may: (1) confirm patellofemoral uptake, guiding isolated patella revision or lateral release, (2) reveal tibial component malalignment with focal uptake at the tibial interface, directing full tibial component revision, or (3) show no significant focal uptake suggesting an extra-articular cause of pain. I would also complement SPECT-CT with synovial fluid aspiration to exclude infection, as SPECT-CT cannot reliably differentiate infection from aseptic loosening.

KEY POINTS TO SCORE

SPECT-CT localises uptake to specific prosthetic compartments (patellofemoral vs tibiofemoral)

Changes diagnosis in approximately 30% of painful TKR cases over planar scan

CT component assesses alignment, osteolysis, and cement mantle

Fusion images identify the specific interface responsible for metabolic activity

Must complement with joint aspiration to exclude infection

COMMON TRAPS

✗Accepting broad planar scan uptake without seeking compartmental localisation

✗Not mentioning that SPECT-CT cannot reliably exclude infection (need aspiration)

✗Not knowing that normal postoperative uptake resolves by 1-2 years

✗Not describing the dual contribution of both SPECT and CT components

VIVA SCENARIOStandard

EXAMINER

"A 16-year-old cricket fast bowler presents with persistent low back pain. MRI shows bilateral pars defects at L5 but is equivocal for marrow oedema. How would SPECT-CT help?"

EXCEPTIONAL ANSWER

This is an excellent indication for SPECT-CT because the key clinical question is not just whether pars defects exist (MRI and CT can show this), but whether they are metabolically ACTIVE — which determines healing potential and guides management. SPECT component: If the pars defects show increased Tc-99m MDP uptake on SPECT, this indicates active metabolic activity at the fracture site — either an active stress reaction or a recent fracture with healing potential. Active SPECT uptake tells us the defect is biologically responsive and has a significantly better chance of healing with conservative treatment (bracing for 6-12 weeks, activity modification). If there is NO SPECT uptake at the pars defects, this indicates a chronic, established non-union — the fracture site is metabolically quiescent, and healing with bracing is unlikely. Management in this case is symptom-based conservative treatment rather than expectation of fracture healing. CT component: Provides high-resolution structural assessment of the pars defects — is there reactive sclerosis (suggesting chronicity)? Is there a clear fracture gap? Is there any bridging callus (suggesting healing)? CT also assesses for any associated disc pathology or listhesis. Fusion image: Precisely localises the SPECT uptake to the pars interarticularis, excluding other causes of lumbar uptake (facet joint disease, vertebral body stress fracture, spinous process avulsion). In this case, the equivocal MRI makes SPECT-CT particularly valuable. SPECT has higher sensitivity (97%) for active pars stress reactions compared to MRI (85%). Active bilateral pars uptake would prompt me to recommend aggressive conservative management with a Boston brace for 12 weeks, cessation of fast bowling, and follow-up imaging to confirm healing.

KEY POINTS TO SCORE

SPECT determines biological activity: active uptake = healing potential, no uptake = established nonunion

CT shows structural defect status: gap, sclerosis, callus, associated pathology

SPECT sensitivity for active spondylolysis is 97% (higher than MRI at 85%)

Active defects: brace for 12 weeks + activity modification (aiming for healing)

Inactive defects: symptom-based conservative management (healing unlikely)

COMMON TRAPS

✗Not understanding that SPECT shows ACTIVITY, not just structure

✗Not differentiating active (healable) from chronic (non-healing) defects

✗Not mentioning radiation dose consideration in a young patient

✗Recommending the same management regardless of SPECT activity

VIVA SCENARIOChallenging

EXAMINER

"An examiner asks you to compare SPECT-CT, PET-CT, and planar bone scan for orthopaedic applications."

EXCEPTIONAL ANSWER

These three modalities represent a spectrum of nuclear medicine imaging capabilities, each with specific strengths and appropriate clinical roles. Planar bone scan (Tc-99m MDP): This is the workhorse of skeletal nuclear medicine. It provides a 2D whole-body skeletal survey with high sensitivity for osteoblastic activity. Strengths: whole-body coverage in a single study (ideal for metastatic screening), widely available, relatively low cost and dose (approximately 5 mSv), well-validated for decades. Limitations: 2D imaging provides poor anatomical localisation in complex regions, limited spatial resolution (10-15mm), and low specificity (cannot differentiate causes of hot spots). Best for: initial metastatic screening (particularly osteoblastic metastases), survey of systemic bone disease. SPECT-CT: An upgrade of the bone scan concept into 3D with anatomical co-registration. Uses the same Tc-99m MDP tracer but acquires data from multiple angles to create a volumetric dataset, combined with CT. Strengths: better contrast resolution than planar (detects 20-30% more lesions), precise anatomical localisation via CT fusion, adds diagnostic value in approximately 30% of cases over planar, moderate additional dose (3-10 mSv). Limitations: regional study (not whole-body — requires targeted acquisition), SPECT resolution is still limited (7-10mm), CT component is low-dose and not diagnostic quality. Best for: painful arthroplasty evaluation, specific facet joint identification, spondylolysis activity assessment, localisation of uptake in complex anatomy. PET-CT (F-18 FDG): Uses a fundamentally different tracer (glucose analogue) and detector system (coincidence detection of 511 keV photons). Strengths: superior spatial resolution (4-5mm), detects metabolic activity rather than osteoblastic activity (so detects lytic lesions, soft tissue disease, myeloma), whole-body staging capability, better specificity for tumour vs benign lesions. Limitations: expensive, less widely available, higher dose (10-25 mSv), not specific for bone (FDG accumulates in any metabolically active tissue including infection, inflammation, and normal healing), less sensitive than bone scan for purely osteoblastic metastases. Best for: tumour staging and restaging, lytic metastatic disease, assessment of treatment response, infection evaluation (alternative to WBC scan). In summary: planar bone scan is the screening tool, SPECT-CT is the problem-solver for specific localisations, and PET-CT is the comprehensive staging tool.

KEY POINTS TO SCORE

Planar: whole-body screening, high sensitivity, poor localisation and specificity

SPECT-CT: 3D regional study with anatomical localisation — the problem-solver

PET-CT: highest resolution, detects lytic lesions and soft tissue — the comprehensive stager

Different tracers: Tc-99m MDP (bone turnover) vs F-18 FDG (metabolic activity)

Each has a specific role — they are complementary, not interchangeable

COMMON TRAPS

✗Suggesting one modality replaces all others

✗Not knowing the different tracers and what they detect

✗Not mentioning dose differences between the modalities

✗Not understanding that PET-CT detects lytic lesions (which bone scan misses)